Tag Archives: Merck

Trump slams Merck CEO for resigning from White House council after Charlottesville controversy

Trump slams Merck CEO for resigning from White House council after Charlottesville controversy“America’s leaders must honor our fundamental values by clearly rejecting expressions of hatred, bigotry and group supremacy,” Frazier said in a statement.



Yahoo News – Latest News & Headlines

FDA puts hold on Merck multiple myeloma trials after deaths

FDA puts hold on Merck multiple myeloma trials after deaths(Reuters) – Merck & Co said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its Keytruda in combination with other medicines for the blood cancer after more deaths were reported in patients receiving the Merck immunotherapy. The rare setback for Keytruda sent Merck shares more than 1 percent lower. Merck has been on a roll with the medicine, jumping to the front of the pack of companies with new immuno-oncology drugs, particularly after Keytruda extended survival as an initial treatment for advanced lung cancer, by far the largest oncology market.



Yahoo News – Latest News & Headlines

Merck places children’s HIV drug in shared non-profit patent pool

U.S. drugmaker Merck & Co has contributed an HIV medicine for children to an international shared patent pool in a move that should speed the development of cheap pediatric formulations for use in poor countries. The non-profit Medicines Patent Pool (MPP), which aims to persuade leading drug companies to share rights to their products with generic manufacturers, said on Tuesday the deal for Merck’s raltegravir would add to the treatment arsenal. Merck has not previously participated in the scheme.
Sexual Health News Headlines – Yahoo! News

Merck second quarter profit tops estimates on strong consumer sales

A view of the Merck & Co. campus in Linden, New Jersey(Reuters) – Merck & Co Inc reported better-than-expected quarterly results on Tuesday, with sales of consumer products and medicines for arthritis and HIV helping to offset the impact of generic competition on other drug sales. Merck, the No. 2 U.S. drugmaker, earned $ 2.03 billion, or 68 cents per share, in the second quarter. Analysts, on average, expected 81 cents, according to Thomson Reuters I/B/E/S. Global revenue slipped 1 percent to $ 10.93 billion, but exceeded expectations of $ 10.6 billion. On May 6, it agreed to sell its consumer care business to Germany’s Bayer AG for $ 14.2 billion, and expects to close the deal in the second half of the year.



Sexual Health News Headlines – Yahoo! News

Merck to pay $100 million in NuvaRing contraceptive settlement

(Reuters) – Merck & Co said on Friday it will pay $ 100 million to resolve all U.S. product liability lawsuits alleging it downplayed serious health risks involving its NuvaRing intrauterine contraceptive device. The product, which contains the hormones estrogen and progestin commonly found in birth control bills, is associated with an increased risk of developing blood clots that can cause heart attacks, strokes or sudden deaths. Available to women in the United States since 2001, NuvaRing is one of several contraceptive products linked to this higher risk. Merck, the second-biggest U.S. drugmaker, denied any fault under the agreement, which must be accepted by 95 percent of about 3,800 eligible patients involved in lawsuits pending in federal and state courts.
Sexual Health News Headlines – Yahoo! News

Merck experimental vaccine shows promise in cancer trial: WSJ

(Reuters) – Merck & Co Inc’s experimental cancer vaccine appeared to provide broader protection against a cancer-causing virus than the company’s Gardasil shot did in clinical trials, the Wall Street Journal said on Sunday. Officials at Merck were not immediately available to comment. The article said Merck expects health-care providers to eventually switch to V503 if the product receives marketing approval. Gardasil, launched in 2006, was the first vaccine to protect against human papillomavirus, or HPV, a sexually transmitted virus that can cause cervical cancer in women and other less-common types of cancer in males and females.
Sexual Health News Headlines – Yahoo! News

Merck, GSK cut price of cervical cancer shots for poor countries

By Kate Kelland LONDON (Reuters) – Drugmakers Merck and GlaxoSmithKline have cut the price of cervical cancer shots in a deal that will deliver them to poor countries for less than $ 5 a dose. The new record low price for human papillomavirus (HPV) vaccines should mean millions of girls in developing countries can be protected against the disease, the Global Alliance for Vaccines and Immunisations (GAVI) said on Thursday. “By 2020 we hope to reach more than 30 million girls in more than 40 countries,” Seth Berkley, the group’s chief executive, said in a statement announcing the price deal. …
Sexual Health News Headlines – Yahoo! News

Merck quarterly earnings beat forecasts

A view of the Merck & Co. campus in Linden, New Jersey(Reuters) – Merck & Co reported better-than-expected quarterly earnings despite the negative impact of the stronger dollar, with strong sales growth of its vaccines and treatments for diabetes and HIV. The No. 2 U.S. drugmaker on Friday said it earned $ 1.79 billion, or 58 cents per share, in the second quarter. That compared with $ 2.02 billion, or 65 cents per share, in the year-earlier period. Excluding special items, the company earned $ 1.05 per share. Analysts, on average, had expected $ 1.01 per share. Company sales rose 1 percent to $ 12.31 billion, topping Wall Street expectations of $ 12. …



Sexual Health News Headlines – Yahoo! News